πŸ‡ΊπŸ‡Έ FDA
Patent

US 8680132

Spiro-oxindole MDM2 antagonists

granted A61KA61K31/407A61K45/06

Quick answer

US patent 8680132 (Spiro-oxindole MDM2 antagonists) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/407, A61K45/06, A61P, A61P17/00